HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Huang Selected Research

Radiotherapy

7/2022A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus.
1/2022Comparison of dosimetric effects of MLC positional errors on VMAT and IMRT plans for SBRT radiotherapy in non-small cell lung cancer.
1/2021Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study.
1/2021LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer.
12/202014-3-3 σ: A potential biomolecule for cancer therapy.
6/2011The fate of micronucleated cells post X-irradiation detected by live cell imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Huang Research Topics

Disease

85Neoplasms (Cancer)
02/2024 - 10/2004
17Type 2 Diabetes Mellitus (MODY)
05/2024 - 10/2008
15Insulin Resistance
04/2024 - 09/2009
15Inflammation (Inflammations)
11/2023 - 02/2006
15Hepatocellular Carcinoma (Hepatoma)
07/2022 - 01/2012
14Carcinogenesis
03/2023 - 07/2006
13Infections
03/2024 - 05/2004
12Hypertension (High Blood Pressure)
01/2023 - 10/2009
11Neoplasm Metastasis (Metastasis)
02/2024 - 11/2013
10Breast Neoplasms (Breast Cancer)
02/2024 - 01/2014
10Hypoxia (Hypoxemia)
07/2023 - 11/2010
9COVID-19
04/2024 - 11/2020
8Fibrosis (Cirrhosis)
03/2024 - 09/2010
8Lung Neoplasms (Lung Cancer)
12/2023 - 12/2005
7Gestational Diabetes (Gestational Diabetes Mellitus)
05/2024 - 06/2016
7Melanoma (Melanoma, Malignant)
02/2024 - 12/2015
7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2019 - 07/2015
6Heart Failure
01/2024 - 09/2016
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2023 - 11/2013
6Nasopharyngeal Carcinoma
01/2022 - 01/2019
6Neural Tube Defects (Exencephaly)
01/2020 - 11/2017
5Ulcerative Colitis
09/2023 - 10/2011
5Triple Negative Breast Neoplasms
05/2023 - 04/2018
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2016
5Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 05/2009
5Leukemia
12/2020 - 01/2014
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 03/2009
4Liver Diseases (Liver Disease)
03/2024 - 05/2019
4Obesity
03/2024 - 02/2012
4Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 01/2013
4Body Weight (Weight, Body)
01/2023 - 03/2015
4Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2019
4Thrombosis (Thrombus)
07/2022 - 11/2013
4Chronic Obstructive Pulmonary Disease (COPD)
06/2022 - 01/2013
4Stomach Neoplasms (Stomach Cancer)
10/2021 - 01/2018
4Pneumonia (Pneumonitis)
03/2021 - 01/2017
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 11/2014
3Hypersensitivity (Allergy)
04/2024 - 10/2019
3Diabetic Nephropathies (Diabetic Nephropathy)
02/2024 - 11/2008
3Myocardial Infarction
02/2024 - 01/2022
3Pancreatitis
08/2023 - 04/2009
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2019
3Sepsis (Septicemia)
01/2023 - 01/2019
3Heart Diseases (Heart Disease)
01/2022 - 01/2021
3Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2016
3Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2019
3Hypoglycemia (Reactive Hypoglycemia)
06/2021 - 03/2016
3Papillary Thyroid Cancer
04/2021 - 04/2013
3Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
06/2023 - 11/2008
18Glucose (Dextrose)FDA LinkGeneric
05/2024 - 10/2008
15Biomarkers (Surrogate Marker)IBA
03/2024 - 05/2009
13Long Noncoding RNAIBA
12/2023 - 04/2013
12DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2009
10MicroRNAs (MicroRNA)IBA
03/2024 - 05/2012
10Messenger RNA (mRNA)IBA
06/2022 - 12/2005
10Insulin (Novolin)FDA Link
01/2020 - 04/2011
9LipidsIBA
01/2024 - 03/2016
6CytokinesIBA
04/2024 - 03/2021
6Phosphotransferases (Kinase)IBA
11/2023 - 01/2019
6RNA (Ribonucleic Acid)IBA
11/2023 - 11/2020
6Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2019
5Blood Glucose (Blood Sugar)IBA
05/2024 - 05/2011
5HMGB1 Protein (HMG1)IBA
02/2024 - 01/2012
5Immune Checkpoint InhibitorsIBA
02/2024 - 01/2019
5CateninsIBA
01/2023 - 01/2019
5Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2020 - 09/2018
5CholesterolIBA
01/2019 - 03/2009
4Hemoglobins (Hemoglobin)IBA
05/2024 - 10/2004
4AutoantibodiesIBA
04/2024 - 01/2017
4bisphenol AIBA
01/2024 - 09/2011
4C-Reactive ProteinIBA
11/2023 - 05/2009
4Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
11/2023 - 10/2017
4Transfer RNA (tRNA)IBA
08/2023 - 01/2020
4Histones (Histone)IBA
01/2023 - 10/2018
4Sorafenib (BAY 43-9006)FDA Link
07/2022 - 01/2019
4InflammasomesIBA
06/2022 - 01/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 01/2019
4Circular RNAIBA
01/2022 - 01/2018
4ChromatinIBA
01/2022 - 06/2010
4Hypoglycemic Agents (Hypoglycemics)IBA
06/2021 - 08/2011
4Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2020 - 11/2013
4Triglycerides (Triacylglycerol)IBA
01/2019 - 05/2011
3SodiumIBA
01/2024 - 01/2021
3Protein Kinases (Protein Kinase)IBA
11/2023 - 01/2004
3Mitogen-Activated Protein KinasesIBA
11/2023 - 01/2015
3CarcinogensIBA
03/2023 - 02/2017
3LipopolysaccharidesIBA
01/2023 - 01/2019
3oxidized low density lipoproteinIBA
01/2023 - 01/2019
3Chimeric Antigen ReceptorsIBA
12/2021 - 12/2020
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2021 - 01/2017
3AntigensIBA
02/2021 - 12/2015

Therapy/Procedure

32Therapeutics
01/2024 - 12/2006
14Immunotherapy
11/2023 - 12/2011
8Drug Therapy (Chemotherapy)
10/2023 - 12/2015
6Radiotherapy
07/2022 - 06/2011
4Oral Administration
11/2023 - 02/2019
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 09/2009
3Aftercare (After-Treatment)
01/2022 - 11/2003
3Hepatectomy
01/2021 - 01/2019